Nexstim Plc pre-close business update   Press

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Nexstim Plc pre-close business update

 

Press release, Helsinki, 22 December 2016, at 12pm

Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), a medical technology company with a pioneering navigated non-invasive brain stimulation system, today announces a business update for the year ending 31 December 2016.

Navigated Brain Stimulation Customer adoption of Navigated Brain Stimulation (NBS) systems for brain mapping is increasing and current users continue to adopt and incorporate the technology into their clinical practice. New customers at various prestigious institutions, world-wide purchasing the technology include: The University of Iowa; Dell Children's Hospital in Austin, Texas; Vivantes Klinikum Neukölln in Germany; Queen Elizabeth Hospital Birmingham in UK, and; Aarhus University Hospital in Denmark.

The NBS technology was highlighted in multiple clinical presentations at various scientific congresses including: Society for Neuro-Oncology Annual Meeting; 8 th International Symposium on Navigated Brain Stimulation in Neurosurgery and Neuromodulation; Congress of Neurological Surgeons Annual Meeting; Deutsche Gesellschaft für Neurochirurgie; 20 th Scandinavian Course in Neurosurgery; European Association of Neurosurgical Societies Congress; 10 th Meeting of the European Low Grade Glioma Network; American Epilepsy Society Meeting, and; American Association of Neurological Surgeons Annual Meeting.

In line with the Company's strategic direction, progress is being made to partner with independent distributors in the U.S. to advance commercial efforts for Nexstim's NBS for brain mapping.

Navigated Brain Therapy As separately announced yesterday, Nexstim received a positive response and comments from the US Food and Drug Administration on its limited size trial protocol for the proposed Post-Stroke Motor Recovery Trial. The positive response paves the way for a new 60 patient trial with Nexstim's Navigated Brain Therapy (NBT®) in 2017 and Nexstim expects to receive de novo 510(k) clearance in Q4 2018.

In Europe, commercial steps are being conducted around NBT®, working with early adopter clinicians.

Financing The financing arrangement in the form of a joint deal with Bracknor and Sitra continues on track. Since the beginning of the arrangement announced on 18 August 2016, Nexstim has issued new shares worth EUR 7.7 million in total. The current cash and cash generated from sales, the financing arrangements with Bracknor and Sitra, combined with the strategic changes in the organisation, is estimated to finance the Company until early 2018.

The full year 2016 financial results will be published on Tuesday, February 28, 2017.

Commenting on the business update, Martin Jamieson, CEO of Nexstim, said: "2016 has been a very important year for the Company with significant clinical and financial developments. We continue to make good progress in many key areas and look forward to moving these forward in 2017."

NEXSTIM PLC Martin Jamieson, CEO

Further information is available on the website www.nexstim.com or by telephone:

Nexstim                                                                                                           +447715163942 Martin Jamieson, CEO                                                              martin.jamieson@nexstim.com                                                                                                                                               UB Securities Oy (Certified Adviser)                                                          +358 (0)9 2538 0246

Consilium Strategic Communications                                                        +44 (0)20 3709 5700 Mary-Jane Elliott / Ivar Milligan / Laura Thornton                     nexstim@consilium-comms.com

About Nexstim Plc Nexstim is a medical technology company which has pioneered its technology in brain diagnostics with the Navigated Brain Stimulation (NBS) system. It is the first and only FDA cleared and CE marked system based on navigated Transcranial Magnetic Stimulation (nTMS) for pre-surgical mapping of the speech and motor cortices of the brain. Based on the same technology platform, the Company has developed a system called Navigated Brain Therapy (NBT®) which is CE marked for the treatment of chronic neuropathic pain, major depression and stroke. Nexstim shares are listed on the Nasdaq First North Finland and Nasdaq First North Sweden. For more information please visit www.nexstim.com

 

Attachments:

http://www.globenewswire.com/NewsRoom/Attachm...d070966d58

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AWK Adds Fayette Water System With $9M Upgrade Plan

Updated Category News Views 101

Small water systems do not usually collapse in one dramatic heap; they get worn down by scattered pipes, compliance demands, thin staffing and bills nobody wants to raise. That is the backdrop for Pennsylvania American Water’s completed $32.8 million purchase of the Indian Creek Valley Water Authority system. For American Water shareholders, this is the familiar...

Continue Reading
Panama City Beach Rentals: Rules Before the Ocean View

Updated Category News Views 49

A postcard-perfect balcony can hide a remarkably expensive rulebook. That is the unglamorous message in Angie Outlaw’s discussion of vacation-property buying in Panama City Beach: the view may sell the unit, but zoning, association documents, insurance and lender terms determine whether the purchase behaves anything like the income-producing asset a buyer pictured. I...

Continue Reading
JLL’s Facility Management Push Gets a Useful Nod From Frost

Updated Category News Views 63

A Building Breaks Down Long Before the Earnings Call Notices Facility management is the sort of business that gets ignored until an airport system fails, a data-center cooling unit balks, or a workforce cannot use the building it was told to return to. That is why Frost & Sullivan’s 2026 recognition of JLL deserves more than the usual award-season shrug. It points to an...

Continue Reading
Radiology Staffing Gap Deepens as Imaging Demand Rises

Updated Category News Views 91

An imaging order does not mean much if nobody is available to read it, and that plain operational fact sits at the center of Medicus Healthcare Solutions' 2026 report on the radiologist shortage. The report's projected gap of 2,450 full-time-equivalent radiologists in 2027 is troubling enough. Its estimate of a 4,130 FTE shortfall by 2032 is the part that should make...

Continue Reading
Scenthound’s Franchise Award Spotlights a Real Test

Updated Category News Views 92

A clean dog may not sound like a growth story, yet Scenthound has turned that neglected chore into a surprisingly serious franchise proposition. The company has won the International Franchise Association’s Emerging Franchisor Award after building its dog-hygiene concept from a 2015 founding into a network with more than 180 open locations. That is a respectable piece...

Continue Reading
Misunderstood Brands Bets Small Cans Can Scale Growth

Updated Category News Views 177

A tiny cocktail can is a brutal little test of whether a spirits brand has legs. Misunderstood Brands is putting four 100mL offerings on the shelf just as its Wegmans distribution expands across the East Coast, and that combination matters more than another glossy flavor announcement. The company is trying to turn products people discovered in bars and restaurants into...

Continue Reading
The Hanover Survey Puts Small-Business Trust on Trial

Updated Category News Views 121

A dark storefront can apparently erase goodwill faster than plenty of owners want to admit. The Hanover Insurance Group's 2026 Small Business Pulse Report found that 60% of surveyed consumers would temporarily buy from a competitor if their preferred small business shut unexpectedly. More than half would start looking elsewhere within a week. That is not a cute...

Continue Reading
Sinopec’s Algerian Outreach Reveals a Patient Long Game

Updated Category News Views 95

Soft Power Does Not Run a Refinery, but It Matters A short video contest in Algiers will not move an oilfield schedule or settle a hydrocarbons negotiation. That is precisely why this Sinopec-backed event deserves a sober look rather than a chest-thumping one. On Nov. 15, Sinopec Group and the Chinese Embassy in Algeria co-hosted the final of their second youth cultural...

Continue Reading
Hyster-Yale's $125 Million Convertible Debt Shuffle

Updated Category News Views 108

Forklifts do not make headlines often, but debt terms sure can. Hyster-Yale has proposed a $125 million private offering of convertible senior notes due November 15, 2031, with buyers able to take another $18.75 million if the initial purchasers exercise their option. For NYSE:HY holders, this is not a victory lap or a distress flare by itself. It is a refinancing...

Continue Reading
Highway 99 Truck Death Puts Safety Records in Focus

Updated Category News Views 60

A stopped car on a highway shoulder is supposed to be a bad day, not a death sentence. Yet on November 5, 2026, a person helping a relative with a disabled vehicle was killed on northbound Highway 99 in Elk Grove after a commercial tractor-trailer allegedly drifted onto the shoulder, hit both stationary vehicles, and overturned. Northbound lanes were closed for hours. A...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Work Protective Gear to Enhance Safety and Comfort

Updated Category News Views 209

Revolutionizing Workplace Safety with New Gear Workplace injuries remain a significant concern across various job sites, with issues such as severe cuts and long-lasting knee damage becoming all too common. These challenges not only compromise the well-being of workers but also inflate costs for employers. Many workers often overlook critical personal protective equipment...

Continue Reading
Exploring Innovations in Toxicology at Upcoming ACMT Meeting

Updated Category News Views 380

Innovative Toxicology Research Unveiled at the 2025 ACMT Meeting In an exciting announcement, the American College of Medical Toxicology (ACMT) is gearing up for its 2025 Annual Scientific Meeting and Symposia, set to take place from April 2 to 6 at the Fairmont Hotel in Vancouver. This year promises an inspiring lineup featuring five days filled with groundbreaking...

Continue Reading
ConnectM Technology Solutions' Live Investor Webinar Invitation

Updated Category News Views 77

ConnectM Announces Exclusive Investor Webinar ConnectM Technology Solutions, Inc. (NASDAQ: CNTM), a pioneering technology firm in the electrification economy, is hosting a special investor webinar on March 4, at 4:15 p.m. Eastern Time. This event is a unique opportunity to learn about the company's strategies and insights in a rapidly evolving industry. Discover the...

Continue Reading
Deadline for SelectQuote Investors Approaching Soon

Updated Category News Views 177

Investors Urged to Take Action on SelectQuote Losses Attention investors! If you have experienced financial losses in SelectQuote, now is the time to act. Faruqi & Faruqi, LLP is leading the charge in investigating claims on behalf of investors who may have suffered due to the company's recent developments. Investors are proudly encouraged to reach out if they believe...

Continue Reading
Empowering Girls in Sports: NRPA and Nike's Initiative

Updated Category News Views 486

NRPA and Nike Unite for Gender Equity in Youth Sports The National Recreation and Park Association (NRPA) has joined forces with Nike, highlighting a shared commitment to advancing gender equity in youth sports. This partnership emphasizes the necessity of equitable access to sporting opportunities for all youth, especially girls, to ensure they thrive in their...

Continue Reading